Cargando…

Reinfections with Different SARS-CoV-2 Omicron Subvariants, France

We describe 188 patients in France who were successively infected with different SARS-CoV-2 Omicron subvariants, including BA.1, BA.2, and BA.5. Time between 2 infections was <90 days for 50 (26.6%) patients and <60 days for 28 (14.9%) patients. This finding suggests that definitions for SARS-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Nhu Ngoc, Houhamdi, Linda, Delorme, Léa, Colson, Philippe, Gautret, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622229/ https://www.ncbi.nlm.nih.gov/pubmed/36150518 http://dx.doi.org/10.3201/eid2811.221109

Ejemplares similares

High rate of reinfection with the SARS-CoV-2 Omicron variant
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

SARS-CoV-2 reinfection and COVID-19 severity
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Genomic evidence for reinfection with different Omicron subvariants
por: Hirotsu, Yosuke, et al.
Publicado: (2023)

Does SARS-CoV-2 re-infection depend on virus variant?
por: Gautret, Philippe, et al.
Publicado: (2021)

SARS-CoV-2 Reinfection and Severity of the Disease: A Systematic Review and Meta-Analysis
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2023)

Evolutionary characteristics of SARS-CoV-2 Omicron subvariants adapted to the host
por: Tang, Haijun, et al.
Publicado: (2023)

Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France
por: Dao, Thi Loi, et al.
Publicado: (2021)

Protection against Reinfection with the Omicron BA.2.75 Subvariant
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Determinants of reinfection with SARS-CoV-2 Omicron variant
por: Bisharat, N., et al.
Publicado: (2023)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
por: Ke, Hanzhong, et al.
Publicado: (2022)

Rate of SARS-CoV-2 Reinfection During an Omicron Wave in Iceland
por: Eythorsson, Elias, et al.
Publicado: (2022)

Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children
por: Li, Xiaohe, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination and Protection Against Clinical Disease: A Retrospective Study, Bouches-du-Rhône District, Southern France, 2021
por: Fournier, Pierre-Edouard, et al.
Publicado: (2022)

Severity of SARS-CoV-2 Omicron XBB subvariants in Singapore
por: Pung, Rachael, et al.
Publicado: (2023)

Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection
por: Chen, Xiaosu, et al.
Publicado: (2023)

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
por: Gautret, Philippe, et al.
Publicado: (2021)

“Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants”
por: Vera-Lise, Ihm, et al.
Publicado: (2022)

Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022
por: Bastard, Jonathan, et al.
Publicado: (2022)

Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19
por: Colson, Philippe, et al.
Publicado: (2021)

Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes
por: Nchioua, Rayhane, et al.
Publicado: (2022)

The Rise of SARS-CoV-2 (COVID-19) Omicron Subvariant Pathogenicity
por: DeGrasse, David C, et al.
Publicado: (2023)

Monitoring the Circulation of SARS-CoV-2 Variants by Genomic Analysis of Wastewater in Marseille, South-East France
por: Wurtz, Nathalie, et al.
Publicado: (2021)

SARS-CoV-2 reinfection()
por: Romera, I., et al.
Publicado: (2021)

Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant
por: Shete, Anita M., et al.
Publicado: (2022)

Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
por: Yamasoba, Daichi, et al.
Publicado: (2022)

Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75
por: Wang, Qian, et al.
Publicado: (2022)

Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6
por: Dijokaite-Guraliuc, Aiste, et al.
Publicado: (2022)

Emergence of the Omicron SARS-CoV-2 subvariants during the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6
por: Hachmann, Nicole P., et al.
Publicado: (2022)

Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants
por: Moriyama, Miyu, et al.
Publicado: (2023)

Comparison of the replication and neutralization of different SARS‐CoV‐2 Omicron subvariants in vitro
por: Zhang, Yaqing, et al.
Publicado: (2023)

Correction: The Rise of SARS-CoV-2 (COVID-19) Omicron Subvariant Pathogenicity
por: DeGrasse, David C, et al.
Publicado: (2023)

Effects of tea, catechins and catechin derivatives on Omicron subvariants of SARS-CoV-2
por: Shin-Ya, Masaharu, et al.
Publicado: (2023)

Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
por: Chiang, Hsiao-Ling, et al.
Publicado: (2023)

Comparison of SARS-CoV-2 aerosol emission from patients with Omicron BA.1 or BA.2 subvariant infection
por: Zhang, Yidun, et al.
Publicado: (2022)

Clinical characteristics of liver injury in SARS-CoV-2 Omicron variant- and Omicron subvariant-infected patients
por: Deng, Haohui, et al.
Publicado: (2023)

SARS-CoV-2 reinfections during the Delta and Omicron waves
por: Morris, C. Paul, et al.
Publicado: (2022)

Implementation of an in-house real-time reverse transcription-PCR assay to detect the emerging SARS-CoV-2 N501Y variants
por: Bedotto, Marielle, et al.
Publicado: (2021)

Molecular Characterization of AZD7442 (Tixagevimab-Cilgavimab) Neutralization of SARS-CoV-2 Omicron Subvariants
por: Roe, Tiffany L., et al.
Publicado: (2023)

Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status
por: Boschi, Celine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_upj8tes9iu31pt3ff0fvu2q7rq